The Computational Tumor Immunology Core (CTIC)
The Computational Tumor Immunology Core (CTIC)
批准号:
10505677
负责人:
Derin B Keskin
金额:
$25.99万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-01 至 2027-08-31
关键词:
AreaAtlasesAwardCancer PatientCellsClinicalClonal EvolutionCollaborationsDataData AnalysesEpitopesGenomicsHereditary Nonpolyposis Colorectal NeoplasmsImmuneImmunopreventionInterceptLeadLungMalignant NeoplasmsMalignant neoplasm of lungMutationMutation AnalysisNodulePatientsPremalignant NeoplasmProteomicsRNAResearch PersonnelResearch Project GrantsResearch SupportResource SharingRoleScienceServicesThe Cancer Genome AtlasTumor AntigensVaccinesValidationcancer geneticscomputerized toolsexperiencegenomic dataimmunogenicityimprovedinnovationinsertion/deletion mutationneoantigensnew technologynovelprogramssuccesstooltumortumor immunologyvaccine immunogenicityworking group
中文摘要
CTIC Core:项目概要/摘要
计算肿瘤免疫学核心(CTIC)将为CAP-IT CRI研究人员提供最先进的
计算基因组学、肿瘤免疫学、免疫肽组学和空间基因组学服务,
免疫预防a. Lynch综合征(LS;项目1),B。非肺癌
实性结节(NSN),癌前病变(项目2),和c.任何新的CAP-IT项目,
由CAP-IT计划批准。CTIC研究人员包括计算癌症领域的杰出领导者
遗传学、肿瘤免疫学、单细胞分析和空间基因组学。我们拥有丰富的经验,
拟进行的分析。由于CTIC的重点领域是动态的,并且正在迅速发展,我们预计
随着新技术和计算策略的发展,它们将有助于推动项目1和项目2。的
CTIC将成功描述LS和NSN的LNP RNA免疫预防和免疫拦截疫苗
患者,并为CAP-IT提供必要的共享资源,网络范围。
英文摘要
CTIC Core: Project Summary/Abstract
The Computational Tumor Immunology Core (CTIC) will provide CAP-IT CRI researchers with state-of-the-art
computational genomic, tumor immunology, immunopeptidomic, and spatial genomic services to support
research projects for immunoprevention of patients with a. Lynch syndrome (LS; Project 1), b. lung cancer non-
solid nodule (NSN), pre-malignant neoplasms (Project 2), and c. any new CAP-IT projects that are subsequently
approved by the CAP-IT program. CTIC investigators include accomplished leaders in computational cancer
genetics, tumor immunology, single-cell profiling, and spatial genomics. We have significant experience with all
proposed analyses to be performed. As the CTIC areas of focus are dynamic and rapidly evolving, we anticipate
incorporating new technologies and computational strategies as they develop to help drive Projects 1 and 2. The
CTIC will successfully delineate LNP RNA immunoprevention and immune interception vaccines for LS and NSN
patients and provide necessary shared resources for the CAP-IT, network-wide.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金